 |
| Kelly Yoder |
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick, rising to North America health lead, as managing director, global head of health & life sciences.
Yoder has more than 20 years of experience driving communications and product marketing strategies for global organizations across pharmaceutical, biotech, medical devices and diagnostics.
She will work closely with rf.Digital, rf.Studio53 and rf.TechLab teams to connect strategy, creative and technology to deliver unified, insight-driven programs that drive influence during a time of shifting stakeholder behaviors and accelerating innovation.
As AI reshapes decision-making across the health ecosystem, RF is investing in capabilities that are more personalized, more relevant, and precision-targeted to how influence works today, according to CEO Kathy Bloomgarden.
“Kelley brings valuable new thinking to our already stellar, award-winning healthcare team, helping to accelerate our innovation-first mindset and global healthcare growth,” she said.
RF is No. 6 in O’Dwyer’s 2026 healthcare rankings with fee income of $74.1M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
Charlie Chapman, a policy advisor to Health & Human Services Secretary Robert Kennedy Jr., has joined BGR’s health & life sciences practice.
